Use of Impella 5.5 in patients with cardiogenic shock as a bridge to decision, recovery, or destination therapy

Abstract

The overall morbidity and mortality rates of cardiogenic shock are high. The Impella 5.5 is a temporary mechanical circulatory support device that treats cardiogenic shock by supporting a failing ventricle. It is used as a bridge to advanced therapy, decision, or recovery. We report our initial experience with this device.

Keywords

• Cardiogenic shock
• Mechanical circulatory support
• Left ventricular assist device
• Right ventricular failure